Welcome back chefboy nice call on the bounce. Well good news, PT was just upgraded to $30 from $23 from Piper Jaffray. The CC yesterday was very encouraging, especially the part about CR845 being either unscheduled or schedule 5. Also the uremic pruritus data seems to indicate a new, unforeseen application for CR845.
News 
Market Data 
Discover 
